CV Information
DR. LEE LAI KUAN
| |
---|---|
Grant's Name,"Project's Title" (Research Period)(Role)[Sponsorship]
| |
1 | FUNDAMENTAL RESEARCH GRANT SCHEME (FRGS), "ELUCIDATION OF THE ROLES OF LYCOPENE FOR THE IMPROVEMENT OF CARDIOMETABOLIC PROFILES AND INFLAMMATORY STATUS IN TYPE II DIABETES MELLITUS" (01.11.2020 - 31.10.2022) (Principal) [ KEMENTERIAN PENGAJIAN TINGGI ] - Source: eR&I |
2 | EXTERNAL AGENCY (INDUSTRY - DTD), "A COLLABORATIVE RESEARCH ON THE DEVELOPMENT OF SACHA INCHI OIL SUPPLEMENTATION FOR HYPERGLYCEMIA, HYPERTENSION AND HYPERLIPIDEMIA IMPROVEMENT" (01.10.2020 - 30.06.2022) (Principal) [ ORIENT BIOTECH SDN. BHD. ] - Source: eR&I |
3 | FUNDAMENTAL RESEARCH GRANT SCHEME (FRGS), "DISASTER RELIEF AND PREPAREDNESS: NUTRITIONALLY-BALANCED, COST EFFECTIVE, SOCIALLY ACCEPTABLE, AND SUSTAINABLE EMERGENCY FOOD AID DESIGN: A VITAL STRATEGY FOR DISASTER ABATEMENT" (01.04.2015 - 31.12.2015) (Principal) [ KEMENTERIAN PENGAJIAN TINGGI ] - Source: eR&I |
4 | , "UNREVEALING THE ROLES OF SACHA INCHI OIL SUPPLEMENTATION ON COGNITIVE FUNCTION, MENTAL HEALTH AND ACADEMIC PERFORMANCE IN HIGHER GRADES PRIMARY SCHOOL CHILDREN : A RANDOMIZED, DOUBLEBLIND, PLACEBO-CONTROLLED HUMAN CLINICAL TRIAL" (01.03.2023 - 28.02.2025) [ Sacha Inchi Manufacturing Sdn. Bhd ] - Source: HCMSv3 |
5 | , "EFFICACY OF TOCOOAT IN METABOLIC SYNDROME (METS): A RANDOMISED HUMAN CLINICAL TRIAL" (01.05.2021 - 30.04.2023) [ Gold Choice Food Industries Sdn. Bhd ] - Source: HCMSv3 |